GoldenGolden
Advanced Search
Antheia (Company)

Antheia (Company)

Antheia is an American biotechnology company founded in 2013, and is located in Menlo Park, California. Antheia uses synthetic biology, informatics, and fermentation technologies to produce plant based medicines; most notably opioids using yeast.

Antheia is an American biotechnology company founded in 2013, and is located in Menlo Park, California. Antheia uses synthetic biology, informatics, and fermentation technologies to produce plant based medicines; most notably opioids using yeast.

Grants
National Science Foundation

Antheia was awarded two grants by the National Science Foundation (NSF): 1) SBIR Phase I: production of plant alkaloid therapeutics via fermentation of engineered yeast on June 20, 2016 with a value of $225,000, and 2) SBIR Phase II: A complete bioprocess for medicinal plant opioids on March 5, 2018 with a value of $733,952.

National Institutes of Health

In 2017 Antheia received two grant awards, the Small Business and Innovation Research (SBIR) award and the Small Business Technology Transfer (STTR) award, from the National Institutes of Health (NIH) worth a total of $450,000.

Funding
Seed

On March 13, 2015 Antheia completed their seed funding round raising $1.97 million.

Series A

On May 26, 2017 Antheia completed their series A funding round raising $6,223,389.

Timeline

July 2, 2021
Antheia raises a $73,000,000 series B round.
March 5, 2018
Received SBIR Phase II award from the National Science Foundation

On March 5, 2018 Antheia was awarded an SBIR Phase II grant titled "A complete bioprocess for medicinal plant opioids" from the National Science Foundation worth $733,952.

May 26, 2017
Series A funding round

On May 26, 2017 Antheia completed their series A funding round raising $6,223,389.

June 20, 2016
Received SBIR Phase I award from the National Science Foundation

Antheia received an SBIR Phase I grant from the National Science Foundation titled "Production of plant alkaloid therapeutics via fermentation of engineered yeast" on June 20, 2016 with a value of $225,000.

March 13, 2013
Seed funding round

On March 13, 2015 Antheia completed their seed funding round raising $1.97 million.

Funding rounds

People

Name
Role
LinkedIn

Christina Smolke

Co-founder , CEO, and President

Isis Trenchard

Co-founder

Kate Thodey

Co-founder

Kristy Hawkins

Co-founder

Ram Shiram

Board member

Further reading

Title
Author
Link
Type
Date

Can This Silicon Valley Startup Bioengineer A Less Addictive Opioid?

Mark Sullivan

Christina Smolke: Fermenting revolution

Erika Check Hayden

New Bioengineering Method Could Change the Way Essential Medicines Are Produced

Glenn McDonald

Documentaries, videos and podcasts

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
FinSMEs
July 1, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Alex Keown
June 30, 2021
BioSpace
Christina Smolke said the financing will enable the company to use its synthetic biology platform to support essential medications that rely on plant-based materials.
Alex Keown
June 30, 2021
BioSpace
Christina Smolke said the financing will enable the company to use its synthetic biology platform to support essential medications that rely on plant-based materials.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.